Regulation & Compliance

The traditional BPO model faces an existential crisis. As AI empowers enterprises, the demand has shifted from cheap labor to intelligent, measurable outcomes.

A new platform promises to shift influencer marketing from gut feel to data science, offering predictive ROI scores for creators with just a username.

Clear Health's Isoclear offers the power of isotretinoin without oral Accutane's strict rules, but its non-FDA-approved status raises critical questions.

A key regulatory win in Abu Dhabi opens a new international front for NeOnc's war on brain tumors, backed by novel science and significant insider buying.

As FAA mandates intensify, a strategic alliance between an insurer and a safety expert signals a pivotal shift from mere compliance to a proactive safety culture.

The real AI threat isn't the model, it's the agent. A new partnership aims to provide the visibility and control government agencies desperately need.

As autonomous AI agents proliferate, enterprises face a chaotic 'shadow AI' landscape. Securden's new platform aims to restore order by unifying security for all identities.

A new study reveals a stark reality: while most companies believe they lead in AI, only 10% truly are. The gap isn't technology—it's transformation.

An Israeli biotech just published a patent for a 'mucoadhesive' gel that makes drugs stick inside the nose. It's a key step in a multi-billion dollar race.

A new report reveals AI isn't the problem in finance; it's the data. Weak foundations are costing firms billions and exposing a critical industry blind spot.

Tigera, the force behind Calico, launches Lynx to rein in chaotic AI agents, offering a kernel-deep control plane for a new era of enterprise security.

As employees flock to prediction markets, a new insider trading risk emerges. A new tech alliance aims to give firms the visibility they've been missing.

With a promising drug and a fortified war chest, Trevi Therapeutics’ upcoming conference tour is a calculated move to conquer a vast, unmet medical need.

At BIO 2026, Israeli biotech Can-Fite seeks crucial partnerships for its late-stage cancer and inflammation drugs, built on a unique, safety-focused platform.

Vercel's new platform isn't just about tools; it's a bet on a future where agents build software. Here's what it means for your business.

Fintech giant Broadridge joins Anthropic's elite Project Glasswing, deploying frontier AI to hunt for threats in the bedrock of global finance.

A $100M deal with Redfin, framed as a partnership, has plunged Zillow into an FTC antitrust battle and a shareholder lawsuit. What happens when innovation blurs into collusion?

As AI incidents surge over 200%, a cyber resilience veteran is launching a command center to contain the chaos. It’s a new frontier of corporate risk.

A return to profit and a 4.6p special dividend signal success for Octopus AIM VCT. But a deeper look reveals a masterclass in strategic exits and a VCT sector at a crossroads.

Beyond the headlines of multi-million dollar settlements lies a complex formula. What truly determines what an injury claim is worth? We break it down.